Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial

Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New site revision listed (v3.5.4) replacing the previous v3.5.3, indicating a platform update to the interface. No changes to trial data or study content are implied by this update.
    Difference
    0.1%
    Check dated 2026-05-15T14:12:30.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    This updates the page’s displayed revision/version number from v3.5.2 to v3.5.3, indicating a minor system or site release.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:24.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:53.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new site revision (v3.4.3) was added and the previous revision (v3.4.2) removed, indicating a routine version update.
    Difference
    0.1%
    Check dated 2026-03-12T02:18:50.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed; the older v3.4.1 funding/operating status notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:41:41.000Z thumbnail image

Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.